Chidamide and orelabrutinib synergistically induce cell cycle arrest and apoptosis in diffuse large B-cell lymphoma by regulating the PI3K/AKT/mTOR pathway.
Journal Information
Full Title: J Cancer Res Clin Oncol
Abbreviation: J Cancer Res Clin Oncol
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Declarations Competing interestsAll authors declare that they have no conflicts of interest. Ethics approval and consent to participateNot applicable. Consent for publicationNot applicable. Competing interests All authors declare that they have no conflicts of interest."
"Funding The work was supported by the Natural Science Foundation of Shandong Province, China (ZR2019MH096), Health Development Promotion Project (BUHA-CPP-001), Bethune Charitable Foundation (HXJH-2022–07). The funding agencies were not involved in the design of the study, the collection, analysis, and interpretation of data, or the writing of the manuscript."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025